Vagus nerve stimulation and drug reduction

Neurology

Volumn 56, Issue 4, 2001, Pages 561-563

  Tatum IV, William O ^a,b,c   Johnson, K D ^b   Goff, S ^b   Ferreira, J A ^b   Benbadis, S R ^a,b   Vale, F L ^a  

^a UNIVERSITY OF SOUTH FLORIDA   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; CARBAMAZEPINE; TIAGABINE; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; EPILEPSY; FEMALE; FOCAL EPILEPSY; FOLLOW UP; GENERALIZED EPILEPSY; HUMAN; LENNOX GASTAUT SYNDROME; MALE; PATIENT SATISFACTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; SEIZURE; TREATMENT OUTCOME; VAGUS NERVE STIMULATION;

EID: 0035957044     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.56.4.561     Document Type: Article

References (10)

1. Vagus nerve stimulation
2. Pharmacology of antiepileptic drug polypharmacy
3. Vagus nerve stimulation for treatment of partial seizures. 2. Safety, side effects, and tolerability
4. The vagus nerve stimulation study group EO1-EO5
5. Enhanced recognition memory following vagus nerve stimulation in human subjects
6. Vagus nerve stimulation therapy for partial onset seizures: A randomized active-control trial
7. Ventricular asystole during vagus nerve stimulation for epilepsy in humans
8. Results of antiepileptic drug reduction in patients with multiple handicaps and epilepsy
9. Adding lamotrigine to valproate: Incidence of rash and other adverse effects
10. A pilot study of mood in epilepsy patients treated with vagus nerve stimulation